Free Trial
One Day Left! MarketBeat All Access Returns to $249 Soon
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion
NASDAQ:COCH

Envoy Medical Q3 2026 Earnings Date & Estimates

Envoy Medical logo
$6.14 -0.53 (-7.88%)
As of 10:43 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Envoy Medical is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. The conference call is scheduled for November 10, 2026 at 9:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call Date
Conference Call
9:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Envoy Medical in Q3 2026

Envoy Medical is expected to post earnings of -$0.70 per share on revenue of $85 thousand. In the same quarter a year earlier Envoy Medical reported -$3.50 per share on revenue of $42 thousand. Envoy Medical last reported on August 10, 2026, posting -$0.70 per share and beating the -$0.80 consensus estimate. Envoy Medical has beaten the consensus EPS estimate in 2 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.70
Expected Revenue
$85 thousand
Prior-Year EPS
-$3.50
Prior-Year Revenue
$42 thousand
Expected Revenue Growth
+102.4%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.70 (Beat by +$0.10)
Last Quarter Revenue
$51 thousand
EPS Beat Rate
2 of last 8 quarters

Prepare for the Q3 2026 Call

Envoy Medical Q3 2026 Earnings FAQ

Envoy Medical (NASDAQ:COCH) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Envoy Medical's Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Envoy Medical to post earnings of -$0.70 per share for Q3 2026.

The consensus revenue estimate for Envoy Medical is $85 thousand for Q3 2026.

Envoy Medical Earnings Headlines

Envoy Medical (NASDAQ:COCH) Stock Gets Price Target Boost from Lake Street Capital
October 29 at 1:54 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31164737
Envoy Medical, Inc. announces 1-for-10 reverse stock split
October 27 at 2:05 PM  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/envoy-medical-inc-announces-1-for-10-reverse-stock-split/ar-AA2gbu2U
A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
October 29 at 1:00 AM  |  Behind the Markets (Ad)
Envoy Medical Shareholders Approve Reverse Stock Split Plan
October 16, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/envoy-medical-shareholders-approve-reverse-stock-split-plan?utm_source=marketbeat.com&utm_medium=referral
Analysts Offer Insights on Healthcare Companies: Envoy Medical (COCH) and CVS Health (CVS)
October 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CVS/pressreleases/7556215/analysts-offer-insights-on-healthcare-companies-envoy-medical-coch-and-cvs-health-cvs/
Envoy Medical Resolves SPAC Litigation, Strengthening Legal Position
October 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/envoy-medical-resolves-spac-litigation-strengthening-legal-position?utm_source=marketbeat.com&utm_medium=referral
See More Envoy Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Envoy Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Envoy Medical and other key companies, straight to your email.

About Envoy Medical

Envoy Medical (NASDAQ:COCH) is a medical technology company focused on developing fully implanted hearing devices for people with sensorineural hearing loss. Unlike conventional hearing aids and many cochlear implants, its technology is designed to be placed beneath the skin, with no external wearable sound processor.

The company’s lead product is the Acclaim Cochlear Implant, a fully implanted cochlear implant intended to address moderate-to-profound sensorineural hearing loss in adults. The system is designed to use the body’s natural anatomy to capture sound and convert it into electrical signals that stimulate the auditory nerve. Envoy Medical has also developed the Esteem Fully Implanted Active Middle Ear Implant, an earlier device based on similar fully implanted hearing technology.

Envoy Medical is headquartered in White Bear Lake, Minnesota, and has focused primarily on the U.S. hearing-loss treatment market. The company was founded in 1995 and became publicly traded in 2023. Brent Lucas serves as chief executive officer. Its Acclaim system has been evaluated through clinical development and regulatory processes as the company works toward broader commercialization.

View Envoy Medical Profile
Earnings Tools